Human beings are the ones who come to mind when we think of dementia. However, new studies indicate that our furry mates, particularly old cats, get a condition whose symptoms are quite close to those of Alzheimer. The syndrome is referred to as feline cognitive dysfunction syndrome (CDS), and it leads to disorientation, alterations in sleeping habits, anxiety, and memory loss in senior cats.
In an innovative study found in European Journal of Neuroscience (2025) it is revealed that CDS cat accumulate amyloid-beta plaques, which are one of the distinctive trademarks of Alzheimer. What is even more alarming is that these plaques stimulate glial cells, which are in most cases the assistants of the brain, to act against the synapses by attacking and engulfing them, hence interfering with the interaction among the neurons.
This finding has not only enhanced our knowledge of feline dementia but has further made cats a model that will naturally occur in Alzheimer disease in human beings.
What is Feline Cognitive Dysfunction Syndrome (CDS)?
Feline CDS is dementia in cats. Symptoms associated with cats of more than 11 years of age include:
Increased night talking
Disturbed social behaviors (clinginess or withdrawal)
Acidity and confusion
Disrupted sleep-wake cycles and house-soiling
According to a research that was referenced in the research study, approximately 28% of cat that is aged between 1114 years and 50% of cats aged more than fifteen years manifest at least one symptom of CDS.
The biological origins of CDS were little noticed until recently. Nevertheless, the new study validates the identification of the same harmful mechanisms present in the brains of humans with Alzheimer disease in the brains of cats.
A Role of Amyloid-Beta in the Aging of Brains
Amyloid-beta (Aβ), a fragment of a protein, is among the most prominent suspects in Alzheimer’s disease, wherein the protein curdles up into plaques in the brain. These plaques interfere with the communication process of the brain, cause toxic pathways, and harm brain cells.
In their new study, the researchers demonstrate that, in aged cats and cats with CDS:
There is amyloid-beta build-up in the synapses.
Astrocytes and microglia (both forms of glial cells) are overactive close to the plaques.
These glial cells wrongly eat up healthy synapses that have amyloid-beta, making the condition of the brain dysfunctional.
Essentially, the cells tasked with brain protection actually attack it, which hastens the loss of synapses, which is the best predictor of cognitive decay in Alzheimer.
The most significant results of the study
The University of Edinburgh and other collaborating researchers closely examined the young, aged, and CDS-infected cats using advanced confocal microscopy on the parietal cortex. What they found was deep:
There is accumulation of amyloid-beta at synapses
There was a lot more amyloid-beta in the synapses of aged and CDS cats compared to younger cats.
Microglial assault on the synapses
The microglia in the area containing large plaques had greater activity, consuming the synapses, in particular, the synapses having amyloid-beta.
Astrocytic involvement
There was also the engulfing of amyloid-laden synapses by astrocytes, another type of glial cell, less aggressively when compared to microglia.
CDS vs. normal aging
There was amyloid pathology in both aged cats and CDS cats but in CDS, the association between amyloid plaques and synaptic destruction was higher implying more toxic actions.
These similarities to Alzheimer in humans are deadly. They state that there is potential in using cats to model natural animals and that it might be helpful in cases where the mouse models designed in laboratories fall short.
Why This is Important in the Research of Alzheimer in People
Mice genetically engineered to form amyloid plaques have served over the decades as the lodestar in the Alzheimer research. Although these models have been helpful, they are incomplete descriptions of what is a very complex situation in humans: disease. Natural to aging cats, however, are amyloid-beta plaques and symptoms of dementia, which make cats a unique anomaly in the world of animal-human studies, an essential stepping stone between animal experiments and human clinical trials.
The results of the study also coincide with recent studies in humans: amyloid-beta itself does not always indicate the levels of dementia. Rather, the crucial factor is correlated with communication between glial cells and synapses. This paves the way for new treatments that target glial activity and protect the synapses.
Pet Owners Implications
This is a sobering yet hopeful research for people who love cats. It underscores the fact that dementia in cats exists and is more widespread than people would say. Signs of confusion, the tendency to vocalize at night, as well as changes in behavior indicate that your aging cat is affected by CDS.
Feline dementia is increasingly recognized by vets, but there is still no cure, although supportive care and modification of the environment may help increase the quality of life. In the meantime, when analyzing feline CDS, scientists bring a step closer to breakthroughs that would bring about benefits to felines and humans.
Conclusion
This pioneering research indicates that in cats, amyloid-beta plaques trigger the engulfment of synapses by glial cells, suggesting involvement of similar events in human conditions of Alzheimer-s disease. Not only does it enlighten our knowledge of feline dementia, but it also provides an excellent naturally occurring model for human research.
In investigating how our cat friends can beat dementia and by investing in this model, the scientists expect to finally develop new methods that could delay or even help prevent the onset of dementia in humans and pets, prolonging their lives and improving their health.
References and Resources
McGeachan RI, Ewbank L, Watt M, et al. Amyloid-Beta Pathology Increases Synaptic Engulfment by Glia in Feline Cognitive Dysfunction Syndrome: A Naturally Occurring Model of Alzheimer’s Disease. European Journal of Neuroscience. 2025;62:e70180. DOI: 10.1111/ejn.70180
Alzheimer’s Research UK. https://www.alzheimersresearchuk.org
American Veterinary Medical Association – Aging and Cognitive Dysfunction in Pets. https://www.avma.org